These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 24071448)
1. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448 [TBL] [Abstract][Full Text] [Related]
2. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors. Di Pizio A; Laghezza A; Tortorella P; Agamennone M ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724 [TBL] [Abstract][Full Text] [Related]
3. Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption. Rubino MT; Agamennone M; Campestre C; Campiglia P; Cremasco V; Faccio R; Laghezza A; Loiodice F; Maggi D; Panza E; Rossello A; Tortorella P ChemMedChem; 2011 Jul; 6(7):1258-68. PubMed ID: 21714093 [TBL] [Abstract][Full Text] [Related]
4. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity. Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024 [TBL] [Abstract][Full Text] [Related]
5. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily. Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9. Nanjan P; Nambiar J; Nair BG; Banerji A Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment. Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies. Das S; Amin SA; Jha T Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437 [TBL] [Abstract][Full Text] [Related]
9. New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy. Marques SM; Abate CC; Chaves S; Marques F; Santos I; Nuti E; Rossello A; Santos MA J Inorg Biochem; 2013 Oct; 127():188-202. PubMed ID: 23597851 [TBL] [Abstract][Full Text] [Related]
10. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. Campestre C; Agamennone M; Tortorella P; Preziuso S; Biasone A; Gavuzzo E; Pochetti G; Mazza F; Hiller O; Tschesche H; Consalvi V; Gallina C Bioorg Med Chem Lett; 2006 Jan; 16(1):20-4. PubMed ID: 16242329 [TBL] [Abstract][Full Text] [Related]
11. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging. Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146 [TBL] [Abstract][Full Text] [Related]
12. New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids. Behrends M; Wagner S; Kopka K; Schober O; Schäfers M; Kumbhar S; Waller M; Haufe G Bioorg Med Chem; 2015 Jul; 23(13):3809-18. PubMed ID: 25921268 [TBL] [Abstract][Full Text] [Related]
13. Enzymatic inhibitory activity of Abu Bakar AR; Ripen AM; Merican AF; Mohamad SB Nat Prod Res; 2019 Jun; 33(12):1765-1768. PubMed ID: 29394875 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes. Freskos JN; Asmelash B; Gaston KR; Karwa A; Marzan TA; Nickols MA; Rogers TE; Schoenstein T; Sympson CJ; Vu B Bioorg Med Chem Lett; 2013 Oct; 23(20):5566-70. PubMed ID: 23999043 [TBL] [Abstract][Full Text] [Related]
15. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9. Kirchhain A; Zubrienė A; Kairys V; Vivaldi F; Bonini A; Biagini D; Santalucia D; Matulis D; Di Francesco F Bioorg Chem; 2021 Oct; 115():105155. PubMed ID: 34303036 [TBL] [Abstract][Full Text] [Related]
16. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors. Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751 [TBL] [Abstract][Full Text] [Related]
17. Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth. Tauro M; Shay G; Sansil SS; Laghezza A; Tortorella P; Neuger AM; Soliman H; Lynch CC Mol Cancer Ther; 2017 Mar; 16(3):494-505. PubMed ID: 28069877 [TBL] [Abstract][Full Text] [Related]
18. MMPREDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil. Zeidán-Chuliá F; Neves de Oliveira BH; Gursoy M; Könönen E; Fonseca Moreira JC; Gursoy UK; Uitto VJ Chem Biodivers; 2013 Apr; 10(4):507-23. PubMed ID: 23576339 [TBL] [Abstract][Full Text] [Related]
19. Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Wang L; Li X; Zhang S; Lu W; Liao S; Liu X; Shan L; Shen X; Jiang H; Zhang W; Huang J; Li H Bioorg Med Chem; 2012 Jul; 20(13):4164-71. PubMed ID: 22658537 [TBL] [Abstract][Full Text] [Related]
20. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects. Li W; Saji S; Sato F; Noda M; Toi M Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]